Dementia looks different with a PhD

August 5, 2008

College grads with MMSE below 27 need dementia testing, says Mayo team

The bar should be set higher in suspecting a diagnosis of early Alzheimer’s among highly educated patients, according to a new report in Archives of Neurology.

A study from the Mayo Clinic Alzheimer Research Center shows that, for college-educated individuals, an MMSE score below 27 is a much better predictor of dementia risk than the customary cutoff score of 24.

The difference is important because highly educated folks with Alzheimer’s decline faster and die sooner, according to the medical literature.

But there’s good news: Higher education also delays the steepest part of the cognitive decline, reports another recent study.

Well-educated people may want to know that physical exercise seems to diminish brain atrophy in Alzheimer’s, according to another new study. (Whether that translates to an effect on cognitive function is not yet determined.)

Other Alzheimer News

dimebon Alzheimer

etanercept Alzheimer speech

Clinical Trials

Scholarly people with memory loss may want to help researchers determine whether mental exercise can delay dementia, by enrolling in a clinical trial that’s testing the question.

Practical Articles/News

Read a review about medical treatment for early Alzheimer’s recently published in Consultant.


Antipsychotics for dementia in elderly–just say no?

June 10, 2008

Any antipsychotic triples risk of serious events for elderly with dementia

Giving antipsychotics of any kind to an elderly person with dementia, even briefly, increases the risk of death or hospitalization by three or four times, according to a new longitudinal study in the Archives of Internal Medicine.

The study of over 40,000 elderly Canadians, equally divided between those living in nursing homes and those in the community, compared people who took antipsychotics with those who did not. The authors felt they have identified only the “tip of the iceberg” in terms of adverse events.

Research/Reviews
The risk of serious consequences in this study is considerably larger than in earlier studies that compared typical and atypical antipsychotics among the elderly.

Another recent study has found non-steroidal anti-inflammatory drugs (NSAIDs) of no value in preventing cognitive decline in Alzheimer dementia.

Clinical Trials
What’s happening in research using statins to treat Alzheimer disease?


Are you forgetting about memory loss?

April 1, 2008

Five million over age 70 have memory loss. One-fourth are chronically ill.

A groundbreaking nationwide longitudinal study has documented the dimensions of dementia. It estimates that 22% of Americans over age 70—more than five million people–have cognitive impairment without dementia.

On average, this progresses to dementia within about 18 months in about 12% of cases, according to the report in the Annals of Internal Medicine. (The rate of progression varies by subtype of cognitive impairment.)

In 24% of elderly patients, cognitive impairment without dementia is associated with a chronic comorbidity such as diabetes or heart disease. The report notes that doctors busy with the medical condition probably often overlook the cognitive issues (perhaps hindering the success of treatment).

The new national results echo earlier studies that associated early dementia with medical comorbidities.

A series of articles and letters in recent issues of the Journal of the American Medical Association pondered whether primary care doctors should begin screening for cognitive impairment in elderly patients.

Practice Guidelines
Look in this category for national guidelines on diagnosing mild cognitive impairment.

Cardiovascular
A recent study suggests best followup tests for cognitive impairment in stroke patients.


Mediterranean diet prolongs life of Alzheimer’s patients

September 20, 2007

A prospective community-based study from Columbia University shows an apparent dose-response relationship between mortality and adherence to a Mediterranean diet among Alzheimer’s patients.

Numerous prior studies have suggested that the low-fat, high-fiber diet may also prevent cognitive decline. (These researchers previously found the Mediterranean diet associated with lower incidence of Alzheimer’s disease.)

Refine Results into Clinically Useful Categories:

Patient Education Materials
Show patients (or their caregivers) how the Mediterranean diet is healthy for the heart.

Practical Articles and News
Find what you can do to help the caregiver of a patient with dementia.